Acute Myeloid Leukemia Clinical Trial

Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants

Summary

RATIONALE: Studying samples of bone marrow from patients with Fanconi anemia and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to Fanconi anemia.

PURPOSE: This laboratory study is evaluating gene function in bone marrow cells from patients with Fanconi anemia and from healthy participants.

View Full Description

Full Description

OBJECTIVES:

Describe the complete hematopoietic transcriptomes of Fanconi cells of every common complementation group (e.g., A, C, G, and F) as well as transcriptomes of neoplastic cells derived from bone marrow of patients with Fanconi anemia.
Define large-scale dynamic gene expression data in these patients.

OUTLINE: This is a multicenter study.

Patients and healthy volunteers undergo bone marrow aspiration or biopsy for biological studies. Samples are analyzed for gene expression profiles using microarray assays.

PROJECTED ACCRUAL: A total of 80 patients and 10 healthy volunteers will be accrued for this study.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

Meets 1 of the following criteria:

Diagnosis of Fanconi anemia

Requires bone marrow aspiration or biopsy for clinical purposes

Healthy volunteer

Over 18 years of age
No known blood abnormality

PATIENT CHARACTERISTICS:

Platelet count > 150,000/mm^3
White Blood Cell(WBC) > 4,000/mm^3
Hemoglobin > 13 g/dL
No clinical signs or symptoms of acute or subacute infection (e.g., viral, bacterial, or fungal)
No allergies to lidocaine or xylocaine

PRIOR CONCURRENT THERAPY:

Not specified

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

90

Study ID:

NCT00896740

Recruitment Status:

Terminated

Sponsor:

OHSU Knight Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Knight Cancer Institute at Oregon Health and Science University
Portland Oregon, 97239, United States

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

90

Study ID:

NCT00896740

Recruitment Status:

Terminated

Sponsor:


OHSU Knight Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider